Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NTRB | US
0.03
0.50%
Healthcare
Medical Instruments & Supplies
31/07/2024
04/10/2024
6.00
6.01
6.01
5.75
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando Florida.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
78.1%1 month
129.2%3 months
123.9%6 months
119.8%-
370.37
5.35
0.02
0.02
-4.55
33.34
-
-5.46M
66.58M
66.58M
-
-462.50
-
-14.30
-60.41
1.53
1.00
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.14
Range1M
3.99
Range3M
5.84
Rel. volume
0.12
Price X volume
32.23K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
HYPR | HYPR | Medical Devices | 0.99 | 71.90M | -1.98% | n/a | 0.24% |
Zentek Ltd. Common Stock | ZTEK | Medical Instruments & Supplies | 0.661 | 68.97M | -4.20% | n/a | 5.91% |
OWLT | OWLT | Medical Devices | 4.5 | 68.49M | 1.81% | n/a | -56.87% |
Milestone Scientific Inc | MLSS | Medical Instruments & Supplies | 0.8823 | 68.19M | -4.45% | n/a | 4.28% |
InspireMD Inc | NSPR | Medical Devices | 2.64 | 67.87M | 1.54% | n/a | 2.83% |
TELA BIO INC | TELA | Medical Devices | 2.7 | 66.73M | 9.76% | n/a | 1442.09% |
Adagio Medical Holdings Inc Common Stock | ADGM | Medical Devices | 2.89 | 55.22M | 1.40% | n/a | 0.00% |
LENSAR Inc | LNSR | Medical Devices | 4.485 | 52.06M | 4.55% | n/a | 5.43% |
electroCore Inc | ECOR | Medical Devices | 7.35 | 47.38M | 1.38% | n/a | 34.63% |
Apyx Medical Corporation | APYX | Medical Instruments & Supplies | 1.275 | 44.17M | 6.83% | n/a | 262.43% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.89 | 19.79M | -2.50% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Rocky Mountain Chocolate Factory Inc | RMCF | Confectioners | 2.04 | 15.49M | 1.49% | n/a | 38.66% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.55 | 7.69 | Cheaper |
Ent. to Revenue | 33.34 | 64.13 | Cheaper |
PE Ratio | - | 50.95 | - |
Price to Book | 5.35 | 6.11 | Par |
Dividend Yield | - | 1.34 | - |
Std. Deviation (3M) | 123.93 | 55.82 | Riskier |
Debt to Equity | 0.02 | 0.86 | Cheaper |
Debt to Assets | 0.02 | 0.26 | Cheaper |
Market Cap | 66.58M | 9.95B | Emerging |